Understanding the specific subtype based on hormone receptor status and HER2 is crucial mainly because estrogen, in its primary form of 17β-estradiol (E2), has a vital role in breast cancer development, particularly in postmenopausal women [1]. Here, ERBB2 is linked to breast carcinoma.